Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRE: Metronidazole Plus IPTp for Malaria and STIs in Pregnancy
NCT04189744Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Dec 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metronidazole in malaria, bacterial vaginosis (BV), sponsored by London School of Hygiene & Tropical Medicine. Started Dec 2019; status: completed.
02
Drugs
metronidazole
03
Conditions
malariabacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT04189744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189744.